This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of the project (EMCDDA)
Bibliography: Interventions – Treatment
Access to hepatitis c treatment and care among people who inject drugs: failing people most disproportionately affected
Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans (heoCoalition)
Release of First-Ever National Clinical Guidelines on Substance Use Disorders among Older Canadians
Canadian healthcare providers now have the tools they need to better support the prevention, assessment and treatment of older adults at risk of, or living with, substance use disorders Canadian Coalition for Seniors’ Mental Health (CCSMH)
Trends in drug-related hospitalisations in Australia, 1999-2018
Each year, the Australian Institute of Health and Welfare (AIHW) makes available to Drug Trends in-depth data on drug-related hospitalisations in Australia from the National Hospital Morbidity Database (NDARC)
Substance misuse treatment for young people: statistics 2018 to 2019
Alcohol and drug treatment data for under-18s from PHE’s National Drug Treatment Monitoring System – NDTMS (Public Health England)
Substance misuse treatment for adults: statistics 2018 to 2019
Statistics on alcohol and drug misuse treatment for adults from PHE’s National Drug Treatment Monitoring System (NDTMS)
HIV and people who inject drugs (PDF)
Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report (ecdc)
Road to Recovery (PDF)
Addiction in our society – the case for reform (Centre for Social Justice)
Hepatitis C interventions (PDF)
Organisations providing harm reduction services in Europe – analysis and examples (European Harm Reduction Network)
Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2019 report (PDF)
The aim of the Unlinked Anonymous Monitoring (UAM) Survey of People Who Inject Drugs (PWID) is to monitor the prevalence and incidence of HIV, hepatitis B and hepatitis C infection, and associated injecting risk behaviour in people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines (Public Health England)
NIH establishes network to improve opioid addiction treatment in criminal justice settings
Ten clinical research centers will address gaps in accessing high-quality care
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017 (HRB, Ireland)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Drug-Related Hospital Statistics Scotland 2017/18
This report describes the number of drug-related hospital stays, the number and characteristics of patients admitted to hospital, the substances involved and the geographical variations within Scotland (ISD)
Alcohol and other drug treatment services in Australia 2017–18: key findings
In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol (34% of all treatment episodes), amphetamines (25%), cannabis (21%) and heroin (5%). Two-thirds (66%) of all clients receiving treatment were male and the median age of clients was 34 years (AIHW)
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017. The number of treated cases increased from 8,361 in 2011 to 9,892 in 2015, and then decreased to 8,922 in 2017
National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD) 2018
On a snapshot day in 2018, just over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,852 dosing points across Australia. There were 3,168 authorised prescribers of opioid pharmacotherapy drugs (AIHW)
Withdrawal Management Services in Canada: The National Treatment Indicators Report (PDF)
The report provides an overview of the use of WM services in Canada in 2015–2016, including episodes of care offered within specialized community-based services and in hospitals (CCSA)
Drug treatment systems in the Western Balkans: outcomes of a joint EMCDDA-UNODC survey of drug treatment facilities
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity of the treatment systems, as well as the availability and provision of treatment intervention (EMCDDA)
Survivors of Multiple Disadvantage Discuss Service & Support (PDF)
A report by Peer Researchers for the National Commission on Domestic and Sexual Violence and Multiple Disadvantage
- 1
- 2
- 3
- …
- 11
- Next Page »
